Table 3. The kinase, miRNA and transcription factor-target networks of EIF2S2 in HCC (LinkedOmics).
Enriched category | Geneset | LeadingEdgeNum | P value | FDR |
---|---|---|---|---|
Kinase target | Kinase_MAPK1 | 54 | 0 | 0.31931 |
Kinase_MAP3K6 | 1 | 0.0042918 | 0.30758 | |
Kinase_DYRK1A | 7 | 0.0043668 | 0.35358 | |
Kinase_CSNK2A1 | 84 | 0.0068493 | 0.63526 | |
Kinase_PIM1 | 8 | 0.011765 | 0.29544 | |
miRNA target | ATACTGT, MIR-144 | 59 | 0 | 0 |
TAGGTCA, MIR-192, MIR-215 | 17 | 0 | 0 | |
TGTTTAC, MIR-30A-5P, MIR-30C, MIR-30D, MIR-30B, MIR-30E-5P | 184 | 0 | 0 | |
TACTTGA, MIR-26A, MIR-26B | 82 | 0 | 0 | |
GCTTGAA, MIR-498 | 33 | 0 | 0 | |
Transcription factor target | GGAANCGGAANY_UNKNOWN | 38 | 0 | 0 |
V$FREAC2_01 | 60 | 0 | 0 | |
YNGTTNNNATT_UNKNOWN | 79 | 0 | 0 | |
V$FREAC4_01 | 42 | 0 | 0.000724 | |
V$FOXO4_02 | 75 | 0 | 0.000905 |
V$, the annotation found in Molecular Signatures; Database (MSigDB) for transcription factors (TF). EIF2S2, eukaryotic translation initiation factor 2 subunit beta; HCC, hepatocellular carcinoma; LeadingEdgeNum, the number of leading edge genes; FDR, false discovery rate from Benjamini and Hochberg from gene set enrichment analysis (GSEA).